Table 2 Description of the cohort of people living with dementia and those who experience psychoactive polypharmacy by duration of psychoactive polypharmacy
|  | Entire Cohort | No psychoactive polypharmacy | Psychoactive polypharmacy < 100 days | Psychoactive polypharmacy 100–500 days | Psychoactive polypharmacy > 500 days |
|---|---|---|---|---|---|
N | 15,819 | 12,765 | 1,179 | 1,491 | 384 |
Women (%) | 11,051 (69.9) | 8,961 (70.2) | 772 (65.5) | 1044 (70.0) | 274 (71.3) |
Men (%) | 4,768 (30.1) | 3,804 (29.8) | 407 (34.5) | 447 (30.0) | 110 (28.6) |
Urban (%) | 9,968 (63.0) | 8,075 (63.3) | 759 (64.3) | 901 (60.4) | 233 (60.7) |
Age, in years (SD) | 80.7 (7.83) | 81.1 (7.85) | 79.2 (7.5) | 79.1 (7.5) | 78.5 (7.71) |